Clinical Trial Protocol for Continuous Glucose Monitoring in Critical Care
NCT: NCT07687368 · COMPLETED
Brief Summary
High blood glucose levels (hyperglycaemia) are very common in patients admitted to intensive care units (ICUs) and are associated with worse health outcomes. Traditionally, glucose levels in critically ill patients are monitored using point-of-care blood glucose (POC-G) testing (fingerstick, arterial, or venous blood samples), which may require multiple measurements each day. Continuous glucose monitoring (CGM) is a technology that measures glucose levels continuously throughout the day and night, providing real-time information and alerts when glucose levels are too high or too low. Previous studies have shown that CGM can be used safely in critically ill patients and may reduce the number of blood glucose tests required. However, more evidence is needed to determine whether CGM improves glucose control and patient outcomes in the ICU. The purpose of this study is to compare CGM-based glucose management with standard point-of-care glucose testing in critically ill patients with hyperglycaemia admitted to the Hospital Clínic of Barcelona. Participants will be randomly assigned to one of two groups. In the experimental group, healthcare professionals will use real-time CGM data to make glucose management decisions. In the control group, glucose management will be based on standard point-of-care testing, while CGM data will be collected in the background for later analysis. The study will evaluate whether CGM improves the amount of time that glucose levels remain within the target range, reduces episodes of high and low glucose, decreases the number of blood glucose tests required, and influences patient outcomes such as complications, hospital readmissions, and mortality up to 90 days after ICU discharge. Researchers hope that the results of this study will help determine whether CGM should become part of routine ICU care, improving patient safety, reducing the burden of glucose monitoring, and supporting more efficient clinical decision-making.
Frequently Asked Questions
What is Clinical Trial Protocol for Continuous Glucose Monitoring in Critical Care?
Clinical Trial Protocol for Continuous Glucose Monitoring in Critical Care is a clinical trial registered under NCT07687368. Current status: COMPLETED.
What is the status of NCT07687368?
The current status of NCT07687368 (Clinical Trial Protocol for Continuous Glucose Monitoring in Critical Care) is: COMPLETED.
When did Clinical Trial Protocol for Continuous Glucose Monitoring in Critical Care start?
Clinical Trial Protocol for Continuous Glucose Monitoring in Critical Care started on 2025-06-14.
Related Devices
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.